News | December 18, 2023
Biocon Biologics concludes integration of acquired Biosimilars business in 120 countries
10+ emerging markets, Japan & ANZ transition in final phase
10+ emerging markets, Japan & ANZ transition in final phase
Receives registration of Valganciclovir powder for oral solution in Germany
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Leading USA based genetic testing brand officially enters the Indian market
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
The new ECO grade is made using renewable feedstock
Subscribe To Our Newsletter & Stay Updated
